Andrew Phillips
Equibles does not estimate personal net worth.
About Andrew Phillips
Andrew Phillips is recorded as CEO at C4 Therapeutics, Inc. (CCCC). The proxy statement of C4 Therapeutics, Inc. reports total compensation of $618,275 for Andrew Phillips in fiscal 2020, including a base salary of $94,500. Disclosed compensation is on record for 2 fiscal years. C4 Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at C4 Therapeutics, Inc. includes Andrew J. Hirsch (CEO), Ron Cooper (Chairman and Board Member), Kendra R. Adams (CFO and Chief Accounting Officer) and 7 others.
Affiliation history
-
Current
Company network
Leadership on record at C4 Therapeutics, Inc.
- Andrew J. Hirsch CEO
- Ron Cooper Chairman, Board Member
- Kendra R. Adams CFO, Chief Accounting Officer
- Lauren White Chief Accounting Officer
- Mark Mossler Chief Accounting Officer
- William T. McKee Chief Accounting Officer
- Adam S. Crystal Board Member
- Donna Grogan, M.D. Board Member
- Laura Bessen, M.D. Board Member
- Owen P. Hughes, Jr. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | C4 Therapeutics, Inc. (CCCC) | Former President & Chief Executive Officer | $94,500 | $618,275 |
| 2019 | C4 Therapeutics, Inc. (CCCC) | Former President & Chief Executive Officer | $520,000 | $4,193,675 |
Recent activity
No call appearances or filed executive changes recorded yet.